SEC Form 4 · accession 0001562180-18-003545
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles R. Kummeth
Officer — Chief Executive Officer · Director
Period of report
Aug 7, 2018
Accepted (ET)
Aug 9, 2018 · 7:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2018 | M | 13,816 | $0.00 | A | 90,288 | D | |
| Common Stock | Aug 7, 2018 | F | 6,301 | $180.14 | D | 83,987 | D | |
| Common Stock | Aug 7, 2018 | F | 1,752 | $180.14 | D | 82,235 | D | |
| Common StockF1,F2 | Aug 8, 2018 | A | 11,279 | $0.00 | A | 93,514 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | — | Aug 7, 2018 | M | 13,816 | D | — | — | Common Stock | 13,816 | 3,467 | D |
| Restricted Stock UnitsF3,F4 | — | Aug 7, 2018 | D | 3,467 | D | — | — | Common Stock | 3,467 | 0 | D |
| Stock Options (Right to buy)F5 | $108.49 | Aug 7, 2018 | D | 23,929 | D | — | Aug 7, 2022 | Common Stock | 23,929 | 95,346 | D |
| Restricted Stock UnitsF3,F6 | — | Aug 8, 2018 | A | 16,918 | A | — | — | Common Stock | 16,918 | 16,918 | D |
| Stock Options (Right to buy)F7 | $177.32 | Aug 8, 2018 | A | 60,222 | A | — | Aug 8, 2025 | Common Stock | 60,222 | 60,222 | D |
| Stock Options (Right to buy)F6 | $177.32 | Aug 8, 2018 | A | 90,334 | A | — | Aug 8, 2025 | Common Stock | 90,334 | 90,334 | D |
| Restricted Stock UnitsF3,F8 | — | holding | — | — | — | — | — | Common Stock | 24,979 | 24,979 | D |
| Restricted Stock UnitsF3,F9 | — | holding | — | — | — | — | — | Common Stock | 21,291 | 21,291 | D |
| Stock Option (Right to Buy)F10 | $108.49 | holding | — | — | — | — | Aug 7, 2022 | Common Stock | 79,517 | 79,517 | D |
| Stock Option (Right to Buy)F11 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 102,779 | 102,779 | D |
| Stock Option (Right to Buy)F8 | $106.59 | holding | — | — | — | — | Aug 18, 2023 | Common Stock | 154,169 | 154,169 | D |
| Stock Option (Right to Buy)F12 | $86.25 | holding | — | — | — | — | Apr 1, 2021 | Common Stock | 46,316 | 46,316 | D |
| Stock Option (Right to Buy)F12 | $67.46 | holding | — | — | — | — | Apr 1, 2020 | Common Stock | 65,000 | 65,000 | D |
| Stock Option (Right to Buy)F12 | $67.46 | holding | — | — | — | — | Apr 1, 2020 | Common Stock | 50,000 | 50,000 | D |
| Stock Options (Right to buy)F9 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 117,342 | 117,342 | D |
| Stock Options (Right to buy)F13 | $125.05 | holding | — | — | — | — | Aug 9, 2024 | Common Stock | 78,228 | 78,228 | D |
| Stock Options (Right to buy)F12 | $94.35 | holding | — | — | — | — | Aug 12, 2021 | Common Stock | 66,849 | 66,849 | D |
Explanation of responses
- F1Restrictions lapse as to 3,760 shares on 8/8/19 and 8/8/20 and as to 3,759 shares on 8/8/21
- F1019,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.
- F11Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20.
- F12Fully exercisable
- F13Vests 19,557 each on 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021
- F2Includes (i) 11,102 shares of restricted stock for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2018 and August 18, 2019; (ii) 14,194 shares of restricted stock for which the risks of forfeiture will lapse with respect to 4,731 shares on each of August 9, 2018 and August 9, 2019 and as to 4,732 shares on August 9, 2020; and (iii) 11,279 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2019 and August 8, 2010 and as to 3,759 shares on August 8, 2021.
- F3Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
- F4On 8/7/2018, the Board of Directors authorized discretionary vesting for 13,816 performance RSUs. The remainder of the performance RSUs were forfeited.
- F5On 8/7/2018, the Board of Directors authorized discretionary vesting for 95,346 performance options. The remainder of the performance options were forfeited.
- F6Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F7Vests 15,056 shares each on 8/8/2019, 8/8/2020, and 15,055 shares each on 8/8/2021, 8/8/2022.
- F8Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
- F9Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).